Werewolf Therapeutics Reports Second Quarter 2021 Financial Results and Business Update

NEXT STORY
Novan Reports Second Quarter 2021 Financial Results and Provides Corporate Update
PREV STORY
EEG Devices Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product ; Application ; Device Type ; End User, and Geography.
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Idorsia to debut at the 39th J.P. Morgan Healthcare Conference – Major catalysts expected in the near-term – Daridorexant NDA submitted to the US FDA

author_avatar
NASDAQ Market News

Rafael Pharmaceuticals Receives FDA Orphan Drug Designation for Treatment of Burkitt Lymphoma, and Initiates a Phase II Clinical Trial of CPI-613 for Patients with Relapsed or Refractory Burkitt Lymphoma/Leukemia

Newark, NJ, June 28, 2018 (GLOBE NEWSWIRE) -- Rafael Pharmaceuticals, Inc., a leader in ...

author_avatar
NASDAQ Market News

Diffusion Pharmaceuticals to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

CHARLOTTESVILLE, Va., Aug. 29, 2018 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” ...

author_avatar
NASDAQ Market News